Vivesto AB 0N4A.L Stock
Vivesto AB Price Chart
Vivesto AB 0N4A.L Financial and Trading Overview
| Vivesto AB stock price | 0.31 SEK |
| Previous Close | 0.4 SEK |
| Open | 0 SEK |
| Bid | 0 SEK x 0 |
| Ask | 0 SEK x 0 |
| Day's Range | 0 - 0 SEK |
| 52 Week Range | 0 - 0 SEK |
| Volume | 13.5K SEK |
| Avg. Volume | N/A |
| Market Cap | 643.78K SEK |
| Beta (5Y Monthly) | 0.076628 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.26 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0N4A.L Valuation Measures
| Enterprise Value | 109.13M SEK |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.21176809 |
| Price/Book (mrq) | 0.7227513 |
| Enterprise Value/Revenue | 35.899 |
| Enterprise Value/EBITDA | -0.873 |
Trading Information
Vivesto AB Stock Price History
| Beta (5Y Monthly) | 0.076628 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0 SEK |
| 52 Week Low | 0 SEK |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
0N4A.L Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | 222.22M |
| Float | 403.81M |
| Short Ratio | N/A |
| % Held by Insiders | 38.85% |
| % Held by Institutions | 4.59% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4272.038% |
| Gross Margin | -283.55% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.72% |
| Return on Equity (ttm) | -72.83% |
Income Statement
| Revenue (ttm) | 3.04M SEK |
| Revenue Per Share (ttm) | 0.006 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -2289000 SEK |
| EBITDA | -124954000 SEK |
| Net Income Avi to Common (ttm) | -350691008 SEK |
| Diluted EPS (ttm) | -0.26 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 119.25M SEK |
| Total Cash Per Share (mrq) | 0.22 SEK |
| Total Debt (mrq) | 7.89M SEK |
| Total Debt/Equity (mrq) | 2.59 SEK |
| Current Ratio (mrq) | 6.201 |
| Book Value Per Share (mrq) | 0.567 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -81846000 SEK |
| Levered Free Cash Flow (ttm) | 89.62M SEK |
Profile of Vivesto AB
| Country | United Kingdom |
| State | N/A |
| City | Solna |
| Address | Gustav III:s Boulevard 46 |
| ZIP | 169 73 |
| Phone | 46 18 50 54 40 |
| Website | https://www.vivesto.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 20 |
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
Q&A For Vivesto AB Stock
What is a current 0N4A.L stock price?
Vivesto AB 0N4A.L stock price today per share is 0.31 SEK.
How to purchase Vivesto AB stock?
You can buy 0N4A.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vivesto AB?
The stock symbol or ticker of Vivesto AB is 0N4A.L.
How many shares does Vivesto AB have in circulation?
The max supply of Vivesto AB shares is 1.57M.
What is Vivesto AB Price to Earnings Ratio (PE Ratio)?
Vivesto AB PE Ratio is now.
What was Vivesto AB earnings per share over the trailing 12 months (TTM)?
Vivesto AB EPS is -0.26 SEK over the trailing 12 months.